Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Benitec Biopharma
(NASDAQ:BNTC)
Intraday
$7.02
0.30
[4.46%]
After-Hours
$7.02
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$7.02
0.30
[4.46%]
At close: Apr 22
$7.02
0
[0.00%]
PreMarket: 5:14PM EDT
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Benitec Biopharma Stock (NASDAQ:BNTC)
Benitec Biopharma Stock (NASDAQ: BNTC)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, April 22, 2024
JMP Securities Maintains Market Outperform on Benitec Biopharma, Raises Price Target to $16
Benzinga Newsdesk
-
17 hours ago
Thursday, April 18, 2024
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
-
4 days ago
Why Is Gene Therapy Developer Benitec Biopharma Stock Trading Higher On Thursday?
Vandana Singh
-
4 days ago
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
-
4 days ago
Benitec Biopharma Shares Halted On Circuit Breaker To The Upside, Stock Now Up 29%
Benzinga Newsdesk
-
4 days ago
Market-Moving News for April 18th
Benzinga Newsdesk
-
4 days ago
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
-
4 days ago
Benitec Biopharma shares are trading higher. The company announced a $40 million oversubscribed private placement financing and reported interim clinical data for the first OPMD subject treated with BB-301 in its Phase 1b/2a study.
Benzinga Newsdesk
-
4 days ago
Benitec Biopharma Reports Interim Clinical Trial Data For First OPMD Subject Treated With BB-301 In Phase 1b/2a Study; Says 'BB-301 facilitated improvements across multiple measures of swallowing function in the first Phase 1b/2a clinical study subject as compared to pretreatment assessments conducted during the observational natural history portion of the study'
Benzinga Newsdesk
-
4 days ago
Benitec Biopharma Reports Oversubscribed Private Placement Financing Of $40M
Benzinga Newsdesk
-
4 days ago
Monday, March 04, 2024
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
-
Mar 4, 2024, 12:34PM
Friday, February 23, 2024
Benitec Biopharma Files For Mixed Shelf Of Up To $125M
Benzinga Newsdesk
-
Feb 23, 2024, 4:14PM
Thursday, February 15, 2024
JMP Securities Maintains Market Outperform on Benitec Biopharma, Raises Price Target to $10
Benzinga Newsdesk
-
Feb 15, 2024, 1:58PM
Tuesday, February 13, 2024
Benitec Biopharma Q2 EPS $(2.64) Up From $(3.34) YoY
Happy Mohamed
-
Feb 13, 2024, 8:06AM
Wednesday, January 24, 2024
JMP Securities Maintains Market Outperform on Benitec Biopharma, Raises Price Target to $8
Benzinga Newsdesk
-
Jan 24, 2024, 12:14PM
Thursday, November 30, 2023
Benitec Biopharma Has Dosed The First Subject In The BB-301 Gene Therapy Phase 1B/2A Trial For Oculopharyngeal Muscular Dystrophy-related Dysphagia
Benzinga Newsdesk
-
Nov 30, 2023, 7:02AM
Monday, November 13, 2023
Benitec Biopharma Q1 EPS $(2.76) Up From $(7.99) YoY
Benzinga Newsdesk
-
Nov 13, 2023, 8:23AM
Tuesday, September 26, 2023
JMP Securities Maintains Market Outperform on Benitec Biopharma, Raises Price Target to $6
Benzinga Newsdesk
-
Sep 26, 2023, 9:01AM
Thursday, September 21, 2023
Benitec Biopharma Releases Full Year 2023 Financial Results And Provides Operational Update; FY23 EPS $(14.12) Vs $(37.88) YoY; Revenue $75K Vs $73K YoY;
Benzinga Newsdesk
-
Sep 21, 2023, 8:19AM
Tuesday, August 22, 2023
Why ProMIS Neurosciences Shares Are Trading Higher By 33%; Here Are 20 Stocks Moving Premarket
Lisa Levin
-
Aug 22, 2023, 8:31AM
Monday, August 21, 2023
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
-
Aug 21, 2023, 5:31PM
Benitec Biopharma 13G Filing Shows Citadel Advisors LLC Holds 6.9% Stake In Co
Happy Mohamed
-
Aug 21, 2023, 4:12PM
Wednesday, August 09, 2023
Why Cutera Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Wednesday's Session
Lisa Levin
-
Aug 9, 2023, 3:17PM
Dow Edges Higher; Tigo Energy Shares Plunge
Lisa Levin
-
Aug 9, 2023, 2:59PM
Benitec Biopharma shares are trading higher. The company announced a $30 million public offering of 15,544,041 shares of its common stock and accompanying warrants at $1.93 per share.
Benzinga Newsdesk
-
Aug 9, 2023, 1:50PM
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
-
Aug 9, 2023, 1:31PM
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
-
Aug 9, 2023, 12:27PM
Benitec Biopharma Shares Resume Trade
Happy Mohamed
-
Aug 9, 2023, 10:37AM
Benitec Biopharma Shares Halted On Circuit Breaker To The Upside, Stock Now Up 120.7%
Happy Mohamed
-
Aug 9, 2023, 10:32AM
Benitec Biopharma Prices $30M Public Offering ~15.54M Shares Of Its Common Stock And Accompanying Warrants At $1.93
Benzinga Newsdesk
-
Aug 9, 2023, 2:14AM
Tuesday, August 08, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
-
Aug 8, 2023, 1:32PM
Friday, August 04, 2023
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
-
Aug 4, 2023, 2:06PM
Wednesday, July 26, 2023
Benitec Biopharma Resume Trades
Benzinga Newsdesk
-
Jul 26, 2023, 10:21AM
Benitec Biopharma Halted On Circuit Breaker To The Upside, Stock Now Up 23.3%
Benzinga Newsdesk
-
Jul 26, 2023, 10:12AM
Tuesday, July 25, 2023
Benitec Biopharma Announces 1-For-17 Reverse Stock Split Effective July 26, 2023
Happy Mohamed
-
Jul 25, 2023, 1:03PM
Wednesday, June 28, 2023
Why Eton Pharmaceuticals Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Lisa Levin
-
Jun 28, 2023, 1:04PM
Tuesday, June 27, 2023
Why Walgreens Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin
-
Jun 27, 2023, 1:56PM
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
-
Jun 27, 2023, 1:37PM
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
-
Jun 27, 2023, 9:12AM
Monday, June 26, 2023
Dow Surges Over 50 Points; Avalo Therapeutics Shares Plummet
Lisa Levin
-
Jun 26, 2023, 3:21PM
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
-
Jun 26, 2023, 1:37PM
Why Carnival Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Lisa Levin
-
Jun 26, 2023, 12:31PM
Crude Oil Rises; Carnival Shares Drop After Q2 Results
Lisa Levin
-
Jun 26, 2023, 12:09PM
JMP Securities Reiterates Market Outperform on Benitec Biopharma, Maintains $4 Price Target
Benzinga Newsdesk
-
Jun 26, 2023, 12:03PM
What In The World Is Going On With Benetic Biopharma (BNTC) Stock
Henry Khederian
-
Jun 26, 2023, 9:28AM
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
-
Jun 26, 2023, 9:12AM
Benetic Biopharma shares are trading higher after the company announced it received FDA clearance of the IND for BB-301 for the treatment of Oculopharyngeal Muscular Dystrophy.
Benzinga Newsdesk
-
Jun 26, 2023, 8:29AM
Benitec Biopharma Receives FDA Clearance Of The IND For BB-301 For The Treatment Of Oculopharyngeal Muscular Dystrophy
Benzinga Newsdesk
-
Jun 26, 2023, 8:02AM
Friday, June 23, 2023
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
-
Jun 23, 2023, 1:37PM
Thursday, May 25, 2023
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
-
May 25, 2023, 1:31PM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch